Fahda M Jamiu Fathima, Gostevcic Nudzejma, Hammad Yasser M, Ahmed Sohel M G
Department of Anaesthesia, Intensive Care and Perioperative Medicine, Hamad Medical Corporation, Doha, Qatar.
Department of Medical Education, Hamad Medical Corporation, Doha, Qatar.
Qatar Med J. 2025 Feb 4;2025(1):23. doi: 10.5339/qmj.2025.23. eCollection 2025.
Diabetes mellitus (DM) is a prevalent condition that requires careful management in the perioperative setting to reduce surgical risks and optimize patient outcomes. The preoperative care of diabetic patients is complex because glucose control must be balanced with minimizing hypoglycemic or hyperglycemic events during surgery. A variety of diabetic medications such as insulin, dipeptidyl-peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and biguanides such as metformin present unique challenges and considerations due to their different mechanisms, benefits, and potential adverse effects. In recent years, professional organizations have developed recommendations on the perioperative management of these therapies, although there remain some variations in guidelines related to medication cessation and dosage adjustments. Standardized protocols in preoperative DM care remain a topic of interest to ensure consistent and safe practices across healthcare settings, and further collaborative research efforts could provide clarity and consensus in managing this diverse patient population.
The objective of this study was to provide an overview of guidelines and practices to support healthcare professionals in delivering improved preoperative care for diabetic patients. This initiative aims to enhance surgical outcomes and minimize the occurrence of complications.
This is a comparative review that provides a systematic comparison of the similarities and differences in the guidelines and recommendations of three professional organizations along with Hamad Medical Corporation. All guidelines were from official websites including Hamad Medical Corporation.
Although the reviewed guidelines for the preoperative care of diabetes patients share some similarities, there are also a number of differences due to outdated data and expert opinions, and therefore differ in practices around the world. While the key elements are agreed upon, more research and global collaboration are needed to create consistent guidelines and improve patient outcomes.
糖尿病(DM)是一种常见疾病,在围手术期需要进行仔细管理,以降低手术风险并优化患者预后。糖尿病患者的术前护理很复杂,因为血糖控制必须在尽量减少手术期间低血糖或高血糖事件的同时取得平衡。各种糖尿病药物,如胰岛素、二肽基肽酶-4抑制剂、胰高血糖素样肽-1受体激动剂、钠-葡萄糖协同转运蛋白-2抑制剂以及双胍类药物(如二甲双胍),由于其不同的作用机制、益处和潜在不良反应,带来了独特的挑战和考量。近年来,专业组织已就这些疗法的围手术期管理制定了建议,尽管在药物停用和剂量调整相关指南方面仍存在一些差异。术前糖尿病护理的标准化方案仍是一个受关注的话题,以确保在不同医疗机构中实施一致且安全的做法,进一步的合作研究努力可为管理这一多样化患者群体提供清晰的指导和共识。
本研究的目的是概述相关指南和实践,以支持医护人员为糖尿病患者提供更好的术前护理。该倡议旨在改善手术预后并尽量减少并发症的发生。
这是一项比较性综述,系统比较了三个专业组织以及哈马德医疗公司的指南和建议中的异同。所有指南均来自官方网站,包括哈马德医疗公司网站。
尽管所审查的糖尿病患者术前护理指南有一些相似之处,但由于数据过时和专家意见不同,也存在一些差异,因此世界各地的实践也有所不同。虽然关键要素已达成共识,但仍需要更多研究和全球合作来制定一致的指南并改善患者预后。